Chris Mason

Founder and Chief Scientific Officer, AvroBIo; Professor of Cell and Gene Therapy, Advanced Centre for Biochemical Engineering, University College London

With over 25 years experience, Chris has had a massive impact on the field of cell and gene therapies. He is currently a Professor of Cell and Gene Therapies at UCL and Founder and Scientific Officer of AVROBIO, a clinical stage company with a focus on developing disruptive lentiviral-based gene therapies.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019